Rallybio Corporation
Rallybio Corporation（RLYB）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · RLYB · 截至 2025年9月30日
股东结构概览
45
机构持有人数
▼ 3 vs Q2
$14.12M
机构持仓总市值
▲ $3.60M vs Q2
5.30M
总流通股
freeFloat 59.57%
28.29M
13F 申报持股数
▼ 2.90M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
RLYB 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP pharmaceutical preparations | 4.19M | 9.31% | 9.31% | $2.09B | Nov 14, 2025 | — held |
JOHNSON & JOHNSON pharmaceutical preparations | 3.64M | 8.07% | 8.07% | $1.81B | Mar 18, 2026 | — held |
5AM VENTURE MANAGEMENT, LLC pharmaceutical preparations | 3.63M | 8.06% | 8.06% | $1.81B | Nov 14, 2025 | — held |
NEW LEAF VENTURE PARTNERS, L.L.C. pharmaceutical preparations | 3.30M | 7.33% | 7.33% | $1.65B | Nov 14, 2025 | — held |
TPG GP A, LLC pharmaceutical preparations | 3.03M | 6.72% | 6.72% | $1.51B | Nov 14, 2025 | — held |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC pharmaceutical preparations | 2.40M | 5.34% | 5.34% | $1.20B | Nov 13, 2025 | — held |
FMR LLC pharmaceutical preparations | 1.69M | 3.76% | 3.76% | $845.50M | Nov 13, 2025 | ▼ 175.9K |
ALMITAS CAPITAL LLC pharmaceutical preparations | 1.54M | 3.41% | 3.41% | $767.83M | Nov 17, 2025 | ▼ 278.8K |
VANGUARD GROUP INC pharmaceutical preparations | 999.6K | 2.22% | 2.22% | $498.81M | Nov 7, 2025 | ▲ 89.7K |
AJU IB INVESTMENT CO., LTD. pharmaceutical preparations | 754.7K | 1.67% | 1.67% | $377.34M | Nov 6, 2025 | — held |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
7
增持
+815.4K 股6
新建仓
首次建仓13
减持
−1.23M 股5
清仓
完全退出净股数变化（前50家）
410.9K
+815.4K / −1.23M
净新增持仓人
-5
新建 6 个 / 退出 5 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
RLYB 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
14
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
ADAR1 Capital Management, LLC 10 percent owner | May 19, 2026 | Purchase | 200 | $13.80 | $2.8K | 926.4K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 19, 2026 | Purchase | 10,000 | $13.98 | $139.8K | 926.2K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 18, 2026 | Purchase | 6,009 | $13.98 | $84.0K | 916.2K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 15, 2026 | Purchase | 200 | $13.95 | $2.8K | 910.1K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 15, 2026 | Purchase | 100 | $13.80 | $1.4K | 909.9K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 13, 2026 | Purchase | 75,178 | $14.00 | $1.05M | 909.8K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 13, 2026 | Purchase | 4,081 | $13.80 | $56.3K | 834.7K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 12, 2026 | Purchase | 800 | $13.83 | $11.1K | 830.6K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 11, 2026 | Purchase | 19,900 | $14.00 | $278.6K | 829.8K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 11, 2026 | Purchase | 25,000 | $14.00 | $350.0K | 809.9K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Rallybio Corporation（RLYB）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 40.43%，散户及公众持股约占剩余的 0.00%。
Rallybio Corporation 最大机构股东为 VIKING GLOBAL INVESTORS LP，截至 September 30, 2025 持有约 4.19 million 股，占总流通股的 9.31%。
目前共有 45 家机构持有 RLYB 股票，合计持仓市值约 $14,121,676，数据来源为最新 SEC 13F 申报。
常见问题
RLYB ownershipRallybio Corporation（RLYB）主要由机构投资者持有，机构持股约 100.0%。最大股东为 VIKING GLOBAL INVESTORS LP，持股比例 9.31%。内部人员持股约 40.43%。数据来源 SEC Form 13F，截至 September 30, 2025。